[Edaily Reporter NA EUN-KYUNG ] Chong Kun Dang ( CHONGKUNDANG(185750)) announced on the 10th that it is launching a new advertising campaign for its high-potency active vitamin “Benfobel S Tablets.”
New advertisement for CHONGKUNDANG’s high-potency active vitamin “Benfobel S Tablets” (Source: CHONGKUNDANG)
Under the slogan “What You Need Right Now Is Benfobel S,” this campaign focuses on conveying the importance of managing fatigue in adults. Actor Heo Seong-tae was selected as the brand ambassador to deliver a message that resonates with people in their 40s and 50s regarding the fatigue they experience in their daily lives.
The commercial is structured to contrast the past and present by incorporating music popular in the early 2010s. It conveys the product’s message by depicting various fatigue-inducing situations that office workers experience in their daily lives, such as company dinners, late-night work, and aging.
CHONGKUNDANG plans to expand brand awareness and product recognition by showcasing the ad primarily through digital channels such as YouTube and Instagram.
“Benfobel S Tablets” is an over-the-counter medication intended for adults aged 19 and older. It contains mecobalamin, used to treat peripheral neuropathy, as well as the active forms of vitamin B1—benfotiamine and bisbenfotiamine—and is formulated to help alleviate physical fatigue by including ursodeoxycholic acid (UDCA), taurine, and methionine.
CHONGKUNDANG official stated, “This campaign is significant in that it conveys a message that resonates with the fatigue adults experience in their daily lives,” adding, “We will work with Heo Seong-tae to raise brand awareness and establish ourselves as a leading brand for adult fatigue management.”
SHEIN, which shook up the global fast-fashion market with its $5 dresses, has seen its valuation shrink by nearly 100 trillion won in just four years. During the COVID-19 pandemic, SHEIN was hailed as…
D&D Pharmatech’s stock price plummeted after Pfizer halted development of MET-224o, an oral obesity treatment candidate acquired through its acquisition of Metsera. However, it has been confirmed that…
Min Ji-young, Olix Pharmaceuticals, Inc.’s New Executive Vice President and CDO. (Photo: Olix Pharmaceuticals, Inc.)
RNA interference (RNAi) therapeutics company Olix Pharmaceuticals, Inc.(226950)…